|
Volumn 14, Issue 6, 2004, Pages 400-406
|
Clinical usefulness of oral itraconazole, an antimycotic drug, for refractory atopic dermatitis
|
Author keywords
Crossover study; Itraconazole; Lactobacillus; Oral administration; Refractory atopic dermatitis; Steroid
|
Indexed keywords
ANTIFUNGAL AGENT;
BIOLACTIS;
IMMUNOGLOBULIN E;
ITRACONAZOLE;
STEROID;
UNCLASSIFIED DRUG;
ADULT;
ANTIBODY TITER;
ARTICLE;
ATOPIC DERMATITIS;
CELL COUNT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG DOSE REDUCTION;
DRUG EFFECT;
EOSINOPHIL;
FEMALE;
HUMAN;
INTERMETHOD COMPARISON;
MALE;
PARAMETER;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTIFUNGAL AGENTS;
CROSS-OVER STUDIES;
DERMATITIS, ATOPIC;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN E;
ITRACONAZOLE;
LACTOBACILLUS;
MALE;
MITOSPORIC FUNGI;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 9244232883
PISSN: 11671122
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (36)
|
References (7)
|